SCHEMBL3220428

SCHEMBL3220428

COC(=O)C(=O)c1oc2ccc(Cc3ccc(F)cc3)cc2c1O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO1 P15559 2/20 0.40
LMNA P02545 2/20 0.38
HTT P42858 1/20 0.38
CNR2 P34972 1/20 0.37
GPR55 Q9Y2T6 1/20 0.37
TP53 P04637 3/20 0.37
RXFP1 Q9HBX9 1/20 0.37
NPSR1 Q6W5P4 3/20 0.37
MAPK1 P28482 1/20 0.37
ANO1 Q5XXA6 1/20 0.36
MAPT P10636 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
POLB P06746 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3220870 0.85 NQO1 (0.44) NQO1LMNAHTTCNR2GPR55
SCHEMBL3225947 0.84 LMNA (0.57) LMNAHTTANO1KMT2A
SCHEMBL13456413 0.77 NQO1 (0.48) NQO1TP53RXFP1MAPTCYP3A4
SCHEMBL3222162 0.75 NQO1 (0.40) NQO1LMNAHTTCNR2GPR55
SCHEMBL6768898 0.73 HSD17B14 (0.39) NQO1LMNAHTTCNR2GPR55
SCHEMBL6720338 0.73 NQO1 (0.53) NQO1LMNAHTTCNR2GPR55
SCHEMBL25338376 0.72 KDM4E (0.49) NQO1LMNAHTTTP53RXFP1
SCHEMBL3224774 0.72 EDNRA (0.53) LMNAMAPTL3MBTL1NPC1RAB9A
SCHEMBL3221505 0.71 LMNA (0.60) LMNAHTTANO1KMT2A
SCHEMBL3869041 0.67 MAPT (0.41) LMNANPSR1MAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100068695-A1 Inhibitor for enzyme having two divalent metal ions as active center KIYAMA RYUICHI 2010-03-18 US disclosed
US-20100068695-A1 Inhibitor for enzyme having two divalent metal ions as active center KIYAMA RYUICHI 2010-03-18 US disclosed
US-20100068695-A1 Inhibitor for enzyme having two divalent metal ions as active center KIYAMA RYUICHI 2010-03-18 US disclosed
US-20040039060-A1 Inhibitor for enzyme having two divalent metal ions as active centers SHIONOGI & CO., LTD. (JP) 2004-02-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040039060-A1 Inhibitor for enzyme having two divalent metal ions as active centers GAA, CMA1, MMEL1 NQO1 633/4885LMNA 4365/4885HTT 4414/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.